Published in Vox Sang on October 01, 1973
Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.99
Human submandibular-sublingual saliva promotes adhesion of Candida albicans to polymethylmethacrylate. Infect Immun (1993) 1.16
Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study. Br J Radiol (2016) 1.00
Isolation and physical characterization of the MUC7 (MG2) mucin from saliva: evidence for self-association. Biochem J (1998) 0.96
Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma. Int J Clin Oncol (2013) 0.88
Role of calcium and PKC in salivary mucous cell exocrine secretion. J Dent Res (2011) 0.84
Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis. BMC Cancer (2015) 0.82
Rheumatoid arthritis - an update for general dental practitioners. Br Dent J (2016) 0.75
A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl (2001) 2.34
Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature (1989) 1.91
Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man. J Dent Res (1987) 1.68
The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. J Biol Chem (1983) 1.67
Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest (1990) 1.54
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3. J Biol Chem (1986) 1.50
Mapping of antigenic determinants of human apolipoprotein B using monoclonal antibodies against low density lipoproteins. J Biol Chem (1982) 1.47
Characterization of monoclonal antibodies against human low density lipoprotein. Arteriosclerosis (1983) 1.44
Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species. J Histochem Cytochem (1985) 1.41
The effects of flow rate and duration of stimulation on the condentrations of protein and the main electrolytes in human parotid saliva. Arch Oral Biol (1969) 1.39
Should 75% of IADR abstracts be rejected? J Dent Res (1990) 1.38
Molecular cloning and expression of partial cDNAs and deduced amino acid sequence of a carboxyl-terminal fragment of human apolipoprotein B-100. Proc Natl Acad Sci U S A (1985) 1.35
Circadian rhythms in human salivary flow rate and composition. J Physiol (1972) 1.34
Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100. J Biol Chem (1990) 1.30
A critical evaluation of some extensible bandages in current use. Nurs Times (1980) 1.24
Circadian rhythms in the flow rate and proportional contribution of parotid to whole saliva volume in man. Arch Oral Biol (1973) 1.19
Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry (1984) 1.19
Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest (1989) 1.16
Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem (1988) 1.15
Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res (1988) 1.13
The surface area of the adult human mouth and thickness of the salivary film covering the teeth and oral mucosa. J Dent Res (1987) 1.08
Apolipoprotein D transcription occurs specifically in nonproliferating quiescent and senescent fibroblast cultures. FEBS Lett (1991) 1.08
Mapping of human apolipoprotein B antigenic determinants. Arteriosclerosis (1987) 1.07
Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res (1993) 1.07
Characterization of monoclonal antibodies against human apolipoprotein E. J Clin Invest (1981) 1.06
Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48. J Biol Chem (1984) 1.05
The contribution of oral minor mucous gland secretions to the volume of whole saliva in man. Arch Oral Biol (1973) 1.03
Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb (1991) 1.01
Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects. J Clin Invest (1984) 1.00
Interactions between mouse immunoglobulins and staphylococcal protein A. Scand J Immunol (1979) 1.00
The effects of electrical and pharmacological stimulation on the types of proteins secreted by rat parotid and submandibular glands. Arch Oral Biol (1978) 1.00
Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. Arterioscler Thromb (1991) 0.99
Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia. J Clin Invest (1986) 0.99
The effects of flow rate and duration of stimulation on the concentrations of protein and the main electrolytes in human submandibular saliva. Arch Oral Biol (1974) 0.98
Well-defined regions of apolipoprotein B-100 undergo conformational change during its intravascular metabolism. Arterioscler Thromb Vasc Biol (2000) 0.98
Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy. J Biol Chem (1991) 0.97
The effects of chewing-gum stick size and duration of chewing on salivary flow rate and sucrose and bicarbonate concentrations. Arch Oral Biol (1993) 0.97
Mechanism of cholesteryl ester transfer protein inhibition by a neutralizing monoclonal antibody and mapping of the monoclonal antibody epitope. J Biol Chem (1989) 0.96
The effects of different foods and concentrations of citric acid on the flow rate of whole saliva in man. Arch Oral Biol (1988) 0.95
In vitro immunosuppressive effect of serum from orally immunized mice. Eur J Immunol (1979) 0.95
Rhythms in salivary flow rate and composition. Int J Chronobiol (1974) 0.94
Cholesteryl ester and apolipoprotein E transfer between human high density lipoproteins and chylomicrons. Biochim Biophys Acta (1983) 0.94
A mathematical model of the influence of salivary urea on the pH of fasted dental plaque and on the changes occurring during a cariogenic challenge. Caries Res (1998) 0.94
Inhibition of cholesteryl ester transfer protein activity by monoclonal antibody. Effects on cholesteryl ester formation and neutral lipid mass transfer in human plasma. J Clin Invest (1989) 0.94
Point mutagenesis of carboxyl-terminal amino acids of cholesteryl ester transfer protein. Opposite faces of an amphipathic helix important for cholesteryl ester transfer or for binding neutralizing antibody. J Biol Chem (1993) 0.93
Structural relationship of human apolipoprotein B48 to apolipoprotein B100. J Clin Invest (1987) 0.93
Pharmacokinetic drug interactions with phenytoin (Part II). Clin Pharmacokinet (1990) 0.91
Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity. J Biol Chem (1992) 0.90
The secretion of magnesium and calcium in human parotid saliva. Caries Res (1967) 0.90
The influence of antigenic stimulation on the ontegeny of lymphoid aggregates and immunoglobulin-containing cells in mouse bronchial and intestinal mucosa. J Reticuloendothel Soc (1975) 0.89
Effects of diet on salivary secretion and composition. J Dent Res (1971) 0.89
Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Eur J Biochem (1984) 0.89
The intra-oral distribution of unstimulated and chewing-gum-stimulated parotid saliva. Arch Oral Biol (1997) 0.89
The volume of saliva in the mouth before and after swallowing. J Dent Res (1984) 0.89
Pharmacokinetic drug interactions with phenytoin (Part I). Clin Pharmacokinet (1990) 0.88
Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses. J Biol Chem (1985) 0.88
The composition of human lip mucous gland secretions. Arch Oral Biol (1973) 0.88
The composition f human saliva secreted in response to a gustatory stimulus and to pilocaprine. J Physiol (1966) 0.87
Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine. Clin Pharmacokinet (1993) 0.87
The influence of previous stimulation and the day of the week on the concentrations of protein and the main electrolytes in human parotid saliva. Arch Oral Biol (1972) 0.87
Apolipoprotein D and cross-reacting human plasma apolipoproteins identified using monoclonal antibodies. J Biol Chem (1986) 0.87
The effects of epinephrine, norepinephrine, and phenylephrine on the types of proteins secreted by rat salivary glands. J Dent Res (1980) 0.87
Thiocyanate levels in human saliva: quantitation by Fourier transform infrared spectroscopy. Anal Biochem (1996) 0.86
Characterization of antigenic determinants of human apolipoprotein B. Distribution on tryptic fragments of low density lipoprotein. Arteriosclerosis (1984) 0.86
Isosteviol reduces plasma glucose levels in the intravenous glucose tolerance test in Zucker diabetic fatty rats. Diabetes Obes Metab (2007) 0.86
Development of salivary alpha-amylase in infants from birth to 5 months. Am J Clin Nutr (1984) 0.85
A mathematical model of salivary clearance of sugar from the oral cavity. Caries Res (1983) 0.85
Localization of the major sites of rabbit apolipoprotein D gene transcription by in situ hybridization. J Lipid Res (1991) 0.85
Circadian rhythms in the flow rate and composition of unstimulated and stimulated human submandibular saliva. J Physiol (1975) 0.85
The effect of flow rate and length of stimulation on the protein concentration in human parotid saliva. Arch Oral Biol (1967) 0.85
Circadian and infradian rhythms in mood. Biomed Pharmacother (2001) 0.85
Salivary flow rates and salivary film thickness in five-year-old children. J Dent Res (1990) 0.85
Apolipoprotein distribution in human lipoproteins separated by polyacrylamide gradient gel electrophoresis. J Lipid Res (1988) 0.85
The effects of chewing frequency and duration of gum chewing on salivary flow rate and sucrose concentration. Arch Oral Biol (1995) 0.84
Salivary clearance of sugar and its effects on pH changes by Streptococcus mitior in an artificial mouth. J Dent Res (1984) 0.84
A comparison of the effects of tasting and chewing foods on the flow rate of whole saliva in man. Arch Oral Biol (1988) 0.84
The effects of exercise on protein and electrolyte secretion in parotid saliva. J Physiol (1981) 0.83
Circadian rhythms in the concentrations of protein and the main electrolytes in human unstimulated parotid saliva. Arch Oral Biol (1973) 0.83
Absence of intestinal synthesis of apolipoprotein B-48 in two cases of abetalipoproteinemia. Gastroenterology (1987) 0.83
Effect of a neutralizing monoclonal antibody to cholesteryl ester transfer protein on the redistribution of apolipoproteins A-IV and E among human lipoproteins. J Lipid Res (1989) 0.83
The effect of taste adaptation on salivary flow rate and salivary sugar clearance. J Dent Res (1987) 0.83
Monoclonal antibodies against human low density lipoprotein. Stoichiometric binding studies using Fab fragments. FEBS Lett (1982) 0.82
Stop-flow effects on human salivary composition and hydrostatic pressures. Arch Oral Biol (1980) 0.82
Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma. J Lipid Res (1998) 0.82
The effect of chewing gums containing calcium phosphates on the remineralization of artificial caries-like lesions in situ. Caries Res (2005) 0.82
The recognition by monoclonal antibodies of various portions of a major antigenic site of human growth hormone. Mol Immunol (1982) 0.82
The effect of swallowing frequency on oral sugar clearance and pH changes by Streptococcus mitior in vivo after sucrose ingestion. J Dent Res (1985) 0.82
Characterization of antigenic determinants on human solubilized apolipoprotein B. Conformational requirements for lipids. J Biol Chem (1984) 0.82
Myrmecia pilosula (Jack Jumper) ant venom: identification of allergens and revised nomenclature. Allergy (2007) 0.82
Fluoride release from new light-cured orthodontic bonding agents. Am J Orthod Dentofacial Orthop (2001) 0.81
Expression of apolipoprotein B epitopes in lipoproteins. Relationship to conformation and function. Arteriosclerosis (1989) 0.81
Testosterone in human saliva. Experientia (1976) 0.81
Cu2(+)-mediated oxidation of dialyzed plasma: effects on low and high density lipoproteins and cholesteryl ester transfer protein. J Lipid Res (1991) 0.81
Neuraminidase activity in the salivary glands of rats and human saliva. Arch Oral Biol (1970) 0.81
Apolipoprotein D--an atypical apolipoprotein. Prog Lipid Res (1991) 0.81
The linkage with apolipoprotein (a) in lipoprotein (a) modifies the immunochemical and functional properties of apolipoprotein B. Biochemistry (1988) 0.81
Suppression of the in vitro immune response by isolated mouse IgG subclasses. Mol Immunol (1980) 0.80
Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets. Eur J Clin Pharmacol (1979) 0.80
Cerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions. Br J Anaesth (2003) 0.80
The quantification of paracetamol, paracetamol glucuronide and paracetamol sulphate in plasma and urine using a single high-performance liquid chromatography assay. J Pharm Biomed Anal (2004) 0.80